In the Press

Aug 22nd, 2023  - Bloomberg

Bloomberg | Drug Benefit Firms Devise New Fees That Go to Them, Not Clients

"Severing the link between fees and drug prices “is probably the most significant thing” Congress could do to change how PBMs operate. Lawmakers are always playing whack-a-mole, and they’re always a little bit behind.” — Spencer Perlman